View in EDS

Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing development.

Saved in:
Bibliographic Details
Title: Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing development.
Authors: Saluzzo F; Vita Salute San Raffaele University, Milan, Italy; IRCCS San Raffaele Scientific Institute, Department of Immunology, Transplantation and Infectious Diseases, Milan, Italy., Yerlikaya S; Department of Infectious Disease and Tropical Medicine, University Hospital Heidelberg, Heidelberg, Germany; German Centre for Infectious Disease Research, DZIF Partner Site Heidelberg, Heidelberg, Germany., Dorman SE; Medical University of South Carolina, Charleston, SC, USA., Eisenach K; TB or NOT TB Consulting, Little Rock, AR, USA., Farhat MR; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA., Ismail N; Department of Clinical Microbiology and Infectious Diseases, National Health Laboratory Service, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Lienhardt C; Unité Mixte Internationale TransVIHMI, Institut de Recherche pour le Développement (IRD), Université de Montpellier, Montpellier, France; Epidemiology and Population Health, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK., Walker TM; Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Jones F; Division of AIDS, National Institutes of Health, Rockville, MD, USA., Yepes A; Global Health Medicines Research and Development, GlaxoSmithKline, Madrid, Spain., Penn-Nicholson A; FIND, Geneva, Switzerland., Ruhwald M; FIND, Geneva, Switzerland., Kana B; School of Pathology, Infectious Diseases and Oncology Research Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Denkinger CM; Heidelberg University Hospital, INF 324, Heidelberg, Germany., Cirillo DM; IRCCS San Raffaele Scientific Institute, Department of Immunology, Transplantation and Infectious Diseases, Milan, Italy. Electronic address: cirillo.daniela@hsr.it.
Source: The Lancet. Infectious diseases [Lancet Infect Dis] 2026 Jun; Vol. 26 (6), pp. e248-e256. Date of Electronic Publication: 2025 Oct 23.
Publication Type: Journal Article; Review
Journal Info: Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42223242
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing development.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Saluzzo+F%22">Saluzzo F</searchLink>; Vita Salute San Raffaele University, Milan, Italy; IRCCS San Raffaele Scientific Institute, Department of Immunology, Transplantation and Infectious Diseases, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Yerlikaya+S%22">Yerlikaya S</searchLink>; Department of Infectious Disease and Tropical Medicine, University Hospital Heidelberg, Heidelberg, Germany; German Centre for Infectious Disease Research, DZIF Partner Site Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Dorman+SE%22">Dorman SE</searchLink>; Medical University of South Carolina, Charleston, SC, USA.<br /><searchLink fieldCode="AU" term="%22Eisenach+K%22">Eisenach K</searchLink>; TB or NOT TB Consulting, Little Rock, AR, USA.<br /><searchLink fieldCode="AU" term="%22Farhat+MR%22">Farhat MR</searchLink>; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ismail+N%22">Ismail N</searchLink>; Department of Clinical Microbiology and Infectious Diseases, National Health Laboratory Service, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.<br /><searchLink fieldCode="AU" term="%22Lienhardt+C%22">Lienhardt C</searchLink>; Unité Mixte Internationale TransVIHMI, Institut de Recherche pour le Développement (IRD), Université de Montpellier, Montpellier, France; Epidemiology and Population Health, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.<br /><searchLink fieldCode="AU" term="%22Walker+TM%22">Walker TM</searchLink>; Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam; Nuffield Department of Medicine, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Jones+F%22">Jones F</searchLink>; Division of AIDS, National Institutes of Health, Rockville, MD, USA.<br /><searchLink fieldCode="AU" term="%22Yepes+A%22">Yepes A</searchLink>; Global Health Medicines Research and Development, GlaxoSmithKline, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Penn-Nicholson+A%22">Penn-Nicholson A</searchLink>; FIND, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Ruhwald+M%22">Ruhwald M</searchLink>; FIND, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Kana+B%22">Kana B</searchLink>; School of Pathology, Infectious Diseases and Oncology Research Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.<br /><searchLink fieldCode="AU" term="%22Denkinger+CM%22">Denkinger CM</searchLink>; Heidelberg University Hospital, INF 324, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Cirillo+DM%22">Cirillo DM</searchLink>; IRCCS San Raffaele Scientific Institute, Department of Immunology, Transplantation and Infectious Diseases, Milan, Italy. Electronic address: cirillo.daniela@hsr.it.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101130150%22">The Lancet. Infectious diseases</searchLink> [Lancet Infect Dis] 2026 Jun; Vol. 26 (6), pp. e248-e256. <i>Date of Electronic Publication: </i>2025 Oct 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101130150 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-4457 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214733099%22">14733099 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Infect Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42223242
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S1473-3099(25)00547-X
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e248
    Titles:
      – TitleFull: Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing development.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Saluzzo F
      – PersonEntity:
          Name:
            NameFull: Yerlikaya S
      – PersonEntity:
          Name:
            NameFull: Dorman SE
      – PersonEntity:
          Name:
            NameFull: Eisenach K
      – PersonEntity:
          Name:
            NameFull: Farhat MR
      – PersonEntity:
          Name:
            NameFull: Ismail N
      – PersonEntity:
          Name:
            NameFull: Lienhardt C
      – PersonEntity:
          Name:
            NameFull: Walker TM
      – PersonEntity:
          Name:
            NameFull: Jones F
      – PersonEntity:
          Name:
            NameFull: Yepes A
      – PersonEntity:
          Name:
            NameFull: Penn-Nicholson A
      – PersonEntity:
          Name:
            NameFull: Ruhwald M
      – PersonEntity:
          Name:
            NameFull: Kana B
      – PersonEntity:
          Name:
            NameFull: Denkinger CM
      – PersonEntity:
          Name:
            NameFull: Cirillo DM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2026 Jun
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1474-4457
          Numbering:
            – Type: volume
              Value: 26
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: The Lancet. Infectious diseases
              Type: main
ResultId 1